Cargando…

Stanniocalcin 2 expression predicts poor prognosis of hepatocellular carcinoma

Previous studies have shown that the expression level of stanniocalcin 2 (STC2) is associated with tumor progression. However, to date, the association between STC2 and clinicopathological factors in hepatocellular carcinoma (HCC) has not been investigated. The clinical significance of STC2 was inve...

Descripción completa

Detalles Bibliográficos
Autores principales:	ZHANG, ZHEN-HAI, WU, YA-GUANG, QIN, CHENG-KUN, RONG, ZHONG-HOU, SU, ZHONG-XUE, XIAN, GUO-ZHE
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2014
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186577/ https://www.ncbi.nlm.nih.gov/pubmed/25289096 http://dx.doi.org/10.3892/ol.2014.2520

Ejemplares similares

Upregulation of microRNA-25 associates with prognosis in hepatocellular carcinoma
por: Su, Zhong-xue, et al.
Publicado: (2014)

Survival analyses correlate stanniocalcin 2 overexpression to poor prognosis of nasopharyngeal carcinomas
por: Lin, Shaojun, et al.
Publicado: (2014)

The Oncogenic and Diagnostic Potential of Stanniocalcin 2 in Hepatocellular Carcinoma
por: Wu, Zhixian, et al.
Publicado: (2022)

Stanniocalcin-1 Reduces Tumor Size in Human Hepatocellular Carcinoma
por: Yeung, Bonnie H. Y., et al.
Publicado: (2015)

Clinical significance of high expression of stanniocalcin-2 in hepatocellular carcinoma
por: Wang, Yuan, et al.
Publicado: (2019)

Effects of stanniocalcin-1 overexpressing hepatocellular carcinoma cells on macrophage migration
por: Leung, Cherry C. T., et al.
Publicado: (2020)

FABP4 suppresses proliferation and invasion of hepatocellular carcinoma cells and predicts a poor prognosis for hepatocellular carcinoma
por: Zhong, Cheng‐Qian, et al.
Publicado: (2018)

Decreased expression of protocadherin 20 is associated with poor prognosis in hepatocellular carcinoma
por: Wu, Yanqin, et al.
Publicado: (2016)

NSUN5 promotes progression and predicts poor prognosis in hepatocellular carcinoma
por: Zhang, Xiao-Wen, et al.
Publicado: (2022)

Expression of Stanniocalcin-1 and Stanniocalcin-2 in Laryngeal Squamous Cell Carcinoma and Correlations with Clinical and Pathological Parameters
por: Zhou, Han, et al.
Publicado: (2014)

Decreased expression of ApoF associates with poor prognosis in human hepatocellular carcinoma
por: Wang, Ya-Bin, et al.
Publicado: (2019)

CHCHD2 promotes hepatocellular carcinoma and indicates poor prognosis of hepatocellular carcinoma patients
por: Yao, Yang, et al.
Publicado: (2019)

Reduced expression of Nrdp1 predicts a poor prognosis in human hepatocellular carcinoma
por: Shao, Xian, et al.
Publicado: (2018)

A poor prognosis in human hepatocellular carcinoma is associated with low expression of DPP4
por: Yu, Hao, et al.
Publicado: (2020)

Allele Loss and Down-Regulation of Heparanase Gene Are Associated with the Progression and Poor Prognosis of Hepatocellular Carcinoma
por: Huang, Guo-Liang, et al.
Publicado: (2012)

Overexpression of ST3Gal-I promotes migration and invasion of HCCLM3 in vitro and poor prognosis in human hepatocellular carcinoma
por: Wu, Han, et al.
Publicado: (2016)

Overexpressed pepsinogen C is associated with poor prognosis in human hepatocellular carcinoma: a tissue microarray study
por: Chen, Hong, et al.
Publicado: (2019)

Elevated expression of Cripto-1 correlates with poor prognosis in hepatocellular carcinoma
por: Wang, Jia-hong, et al.
Publicado: (2015)

Decreased Cezanne expression is associated with the progression and poor prognosis in hepatocellular carcinoma
por: Wang, Jia-hong, et al.
Publicado: (2015)

Decreased CRHBP expression is predictive of poor prognosis in patients with hepatocellular carcinoma
por: Xia, Hai-Bing, et al.
Publicado: (2018)

CBX6 overexpression contributes to tumor progression and is predictive of a poor prognosis in hepatocellular carcinoma
por: Zheng, Hao, et al.
Publicado: (2017)

Low PLCE1 levels are correlated with poor prognosis in hepatocellular carcinoma
por: Cheng, Ya, et al.
Publicado: (2016)

Upregulation of Spondin-2 protein expression correlates with poor prognosis in hepatocellular carcinoma
por: Feng, Ying, et al.
Publicado: (2018)

Decreased expression of serum semaphorin 3B is associated with poor prognosis of patients with hepatocellular carcinoma
por: Li, Guang-Zhen, et al.
Publicado: (2021)

Stanniocalcin-1 promotes tumor angiogenesis through up-regulation of VEGF in gastric cancer cells
por: He, Ling-fang, et al.
Publicado: (2011)

Stanniocalcin2, but Not Stanniocalcin1, Responds to Hypoxia in a HIF1-Dependent Manner in the Retina
por: Ail, Divya, et al.
Publicado: (2022)

High expression of TACC2 in hepatocellular carcinoma is associated with poor prognosis
por: Shakya, Manjul, et al.
Publicado: (2018)

Overexpression of Epcam and CD133 Correlates with Poor Prognosis in Dual-phenotype Hepatocellular Carcinoma
por: Zhang, Jie, et al.
Publicado: (2020)

Expression, function and clinical application of stanniocalcin‐1 in cancer
por: Zhao, Fangyu, et al.
Publicado: (2020)

Upregulated CANT1 is correlated with poor prognosis in hepatocellular carcinoma
por: Liu, Ting, et al.
Publicado: (2023)

Ferroportin in the progression and prognosis of hepatocellular carcinoma
por: Wang, Qin, et al.
Publicado: (2013)

High spindle and kinetochore-associated complex subunit-3 expression predicts poor prognosis and correlates with adverse immune infiltration in hepatocellular carcinoma
por: Zheng, Lin-Lin, et al.
Publicado: (2023)

Positive expression of ZNF689 indicates poor prognosis of hepatocellular carcinoma
por: Yi, Peng Sheng, et al.
Publicado: (2018)

Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma
por: Jiang, Shan-Shan, et al.
Publicado: (2014)

Role of stanniocalcin-1 in breast cancer
por: Chen, Fengxia, et al.
Publicado: (2019)

The significance of Stanniocalcin 2 in malignancies and mechanisms
por: Li, Shasha, et al.
Publicado: (2021)

High Expression of Neuro-Oncological Ventral Antigen 1 Correlates with Poor Prognosis in Hepatocellular Carcinoma
por: Zhang, Yi-An, et al.
Publicado: (2014)

High expression of TOP2A in hepatocellular carcinoma is associated with disease progression and poor prognosis
por: Cai, Hongyu, et al.
Publicado: (2020)

Thymosin β 10 is overexpressed and associated with unfavorable prognosis in hepatocellular carcinoma
por: Song, Chunrong, et al.
Publicado: (2019)

Overexpression of LBH is associated with poor prognosis in human hepatocellular carcinoma
por: Chen, Jiewei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mktc8copj2781h434jbvoa1uvf